Search research articles
Contact Us
Filters
Showing results (191-200 of 313) with videos related to
Page
of 32
Sort By:
American Journal of Hematology
|
December 23, 2016
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
Massimo Gentile, Valeria Magarotto, Massimo Offidani, et al.
British Journal of Haematology
|
May 15, 2009
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia
Fortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
International Journal of Molecular Sciences
|
February 13, 2026
Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia
Martina Cardillo, Fabiana Ferrero, Nadia Bertola, et al.
American Journal of Hematology
|
March 16, 2017
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma
Francesca Romana Mauro, Piero Galieni, Alessandra Tedeschi, et al.
Hematological Oncology
|
July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
Cirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Annals of Hematology
|
August 3, 2017
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study
Artur Jurczyszyn, Alessandro Gozzetti, Joanna Gdula-Argasińska, et al.
Journal of Translational Medicine
|
February 27, 2024
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Frontiers in Oncology
|
March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey
Uros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Leukemia & Lymphoma
|
December 16, 2015
Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study
Annalisa Arcari, Annalisa Chiappella, Michele Spina, et al.
American Journal of Hematology
|
April 9, 2014
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study
Massimo Gentile, Giovanna Cutrona, Laura Mosca, et al.
Page
of 32
Search research articles
Search
Showing results (191-200 of 313) with videos related to
Sort By:
Page
of 32
American Journal of Hematology
|
December 23, 2016
Lenalidomide and low-dose dexamethasone (Rd) versus bortezomib, melphalan, prednisone (VMP) in elderly newly diagnosed multiple myeloma patients: A comparison of two prospective trials
Massimo Gentile, Valeria Magarotto, Massimo Offidani, et al.
British Journal of Haematology
|
May 15, 2009
Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia
Fortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
International Journal of Molecular Sciences
|
February 13, 2026
Intraclonal Enrichment of IL-23 Receptor Complex Expression in the Proliferative Fraction of Chronic Lymphocytic Leukemia
Martina Cardillo, Fabiana Ferrero, Nadia Bertola, et al.
American Journal of Hematology
|
March 16, 2017
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma
Francesca Romana Mauro, Piero Galieni, Alessandra Tedeschi, et al.
Hematological Oncology
|
July 6, 2022
Network meta-analysis of randomized trials in multiple myeloma: Efficacy and safety in frontline therapy for patients not eligible for transplant
Cirino Botta, Emilia Gigliotta, Bruno Paiva, et al.
Annals of Hematology
|
August 3, 2017
Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study
Artur Jurczyszyn, Alessandro Gozzetti, Joanna Gdula-Argasińska, et al.
Journal of Translational Medicine
|
February 27, 2024
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activity
Roberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Frontiers in Oncology
|
March 25, 2021
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey
Uros Markovic, Alessandra Romano, Vittorio Del Fabro, et al.
Leukemia & Lymphoma
|
December 16, 2015
Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study
Annalisa Arcari, Annalisa Chiappella, Michele Spina, et al.
American Journal of Hematology
|
April 9, 2014
Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study
Massimo Gentile, Giovanna Cutrona, Laura Mosca, et al.
Page
of 32